“One of our core values is to be the best and strive to be the first in everything we do. Especially when it comes to our patients, in order to have better and safer treatment, we will be the first to pioneer the latest technique and technology.”
AlignRT & DIBH for Reduced Radiation Toxicity
The Challenge
Shandong Province Hospital was looking for a superior DIBH solution for their young mediastinal lymphoma patients as these patients have an increased risk of lung cancer, breast cancer and cardiovascular disease after radiotherapy. In view of the high survival rate of this disease and patients’ young age, extra care needs to be taken to reduce toxicity after radiation therapy and an accurate and highly reproducible DIBH solution is critical.
Goals
Accuracy
Dose Reduction
Find a technology that will help them effectively reduce dose to lung, breast and heart.
Patient Satisfaction
Develop workflows with AlignRT to provide tattoo and mark-free treatment and enhance the patient experience.
Solution
Shandong Province Hospital has been using AlignRT on thoracic, breast and cervical patients since 2018. In 2020, Vision RT developed a educational plan to maximize the hospitals utilization and technology for better patient outcomes.
Retraining Program
Vision RT’s Clinical Application Specialist visited the site as part of the retraining program and worked with their staff to develop streamlined workflows and increase their knowledge of AlignRT.
New Workflow
The retraining program helped them devise a unique workflow combining the linac’s automatic couch positioning function with AlignRT’s move couch function to position patients efficiently and accurately. This workflow was published in an abstract which was accepted by ASTRO in 2021.
DIBH
The Clinical Application Specialist worked with them to develop DIBH technique for their mediastinal lymphoma patients. Eventually, they moved towards tattoo and mark-free treatment after successful implementation of the workflow.
Results
The use of DIBH with AlignRT reduced:
- Planning Target Volume (PTV) by 28%
- Dose to Heart by 16%
- Dose to Lung by 25%
- Dose to Breast by 35%
Yin Yong
Chief Physicist
Future plans
Shandong Cancer Hospital plans to expand this technique to all their breast cancer patients. In addition, they plan to expand the use of AlignRT to other sites such as SRS treatment.
Contactez-nous.
Utilisez le formulaire à droite et faites-nous savoir si vous souhaitez planifier une démo (virtuelle ou en personne), recevoir une brochure, obtenir un devis d’un membre de notre équipe commerciale ou en savoir plus sur notre analyse de rentabilisation.
);
">